Phio Pharmaceuticals Corp (PHIO)

[Titan V]

Geert from the CC:

In January 2016, we also projected that we would be able to explore human testing on one of our consumers health compounds, also commonly known as functional skin care, before the end of 2016. In order to maintain that promise, we initiated a larger synthesis process with a European manufacturer of [indiscernible] and we should have sufficient quantity of RXI-231 our anti-tyrosinase compound available to start the testing.